ADMA Biologics, Inc.
corporate_fare Company Profile
ADMA Biologics, Inc. (NASDAQ:ADMA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for ADMA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- ADMA Biologics Reports Record 2025 Financial Results, Strong 2026-2029 Guidance, and Smooth CFO Transition
- ADMA Biologics Raises 2026 Guidance, Projects Strong Long-Term Growth to $1.1B Revenue by 2029
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$510.17M
Net Income
$146.93M
Diluted EPS
$0.60
Op. Cash Flow
$50.4M
Free Cash Flow
$27.82M
Gross Profit
$292.76M
Operating Income
$191.44M
Cash & Equivalents
$87.63M
Total Debt
$72.14M
Debt / Equity
0.15×
Net Margin
28.8%
Shares Outstanding
237.87M sh
Source: 10-K · filed 2026-02-25 · accession 0001140361-26-006815
show_chartPrice Chart
Loading chart...